Carl Zeiss Meditec AG (CZMWF)
OTCMKTS · Delayed Price · Currency is USD
50.31
+0.82 (1.66%)
Sep 11, 2025, 1:26 PM EDT
Carl Zeiss Meditec AG Revenue
Carl Zeiss Meditec AG had revenue of 549.63M EUR in the quarter ending June 30, 2025, with 1.91% growth. This brings the company's revenue in the last twelve months to 2.18B, up 5.49% year-over-year. In the fiscal year ending September 30, 2024, Carl Zeiss Meditec AG had annual revenue of 2.07B, down -1.11%.
Revenue (ttm)
2.18B EUR
Revenue Growth
+5.49%
P/S Ratio
1.71
Revenue / Employee
380.41K EUR
Employees
5,730
Market Cap
4.38B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 2.07B | -23.17M | -1.11% |
| Sep 30, 2023 | 2.09B | 186.46M | 9.80% |
| Sep 30, 2022 | 1.90B | 256.05M | 15.55% |
| Sep 30, 2021 | 1.65B | 311.33M | 23.31% |
| Sep 30, 2020 | 1.34B | -123.87M | -8.49% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 105.45M |
| Tian'an Technology Group | 2.12M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| AMJ Global Technology | 39.00 |
Carl Zeiss Meditec AG News
- 5 days ago - Carl Zeiss Meditec: An Odd Reaction To 9M 2025 Earnings - Seeking Alpha
- 7 weeks ago - Kopin, HMDmd start production deliveries of wearable surgical display systems to Carl Zeiss Meditec - Seeking Alpha
- 3 months ago - Carl Zeiss: The Results After 6M25 Are Encouraging For 2025-2027E - Seeking Alpha
- 4 months ago - Carl Zeiss Meditec AG (CZMWF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Carl Zeiss Meditec: Recovery Seems Clear Enough - Seeking Alpha
- 7 months ago - Q1 2025 Carl Zeiss Meditec AG Earnings Call Transcript - GuruFocus
- 10 months ago - Carl Zeiss: Why I Am So Positive - Seeking Alpha
- 1 year ago - My 3 Favorite European Stocks To Diversify Your Portfolio - Seeking Alpha